13:00
May 11

Cannabotech raised NIS 1.2 million in a public offering

11:30
May 10

Together achieved an export permission from Germany to UK

14:00
January 20

Panaxia reports the first export of cannabis tablets to France as part of the pilot in which it participates and is expected to last about two years. The tablets were delivered to France free of charge.

13:00
January 22

Togther reports that the Securities Authority has initiated administrative enforcement proceedings against it in respect of its previous reports from 2018 and 2019 regarding business relations with China.

Israeli Cannabis Sector

May 17, 2022

Revenue growth is expected to continue in the second quarter and throughout 2022 due to organic growth, acquisition of ‘Better’, and international expansion…

April 25, 2022

Cronos and Intercure have similar EV and revenue, but the profitability is very different …

April 7, 2022

The medical cannabis market in Israel is one of the fastest growing in the world. According to data published by the Israeli Medical Cannabis Agency at the Ministry of Health (IMCA), the number of…

March 22, 2022

InterCure (NASDAQ: INCR) and Clever Leaves (NASDAQ: CLVR) today announced the execution of an exclusive multi-year cultivation, marketing and distribution agreement. Over the term of the Agreement, InterCure will have access to Clever Leaves’…

March 16, 2022

Sales will begin after Cann10 receives regulatory approval from the Brazilian Ministry of Health ANVIZA for the marketing and sale of the company’s products in Brazil…

March 9, 2022

Almost all public cannabis companies in Israel have purchased pharmacies lately. This will increase their revenues and market cap …

March 1, 2022

The partnership will focus on the new CBD wellness market in Israel…

February 27, 2022

Betterseeds, one of the Smart Agro portfolio companies, will raise in about $ 70 million valuation…

February 22, 2022

Tikun Olam study is one of the world’s most comprehensive medical cannabis study performed on 8,500 patients …

February 16, 2022

The deal will add to InterCure an estimated NIS 50 million revenue for the upcoming year, and is done in a 1.5 Price/Sales multiplier…

February 14, 2022

The transaction also includes an option to purchase the TelPharm trading house…